"Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation" Is Now Available at Fast Market Research
Pancreatic cancer is the 12th most common cancer globally, and the fourth most fatal, with a mortality rate of 10.9 deaths per 100,000 people per year. The poor prognosis of pancreatic cancer patients has highlighted a significant need for new and improved approaches to treatment, which is not being met by the current market.
View full press release